Growth Hormone Deficiency

Addition of aromatase inhibitor to growth hormone therapy does not improve growth outcomes

A study found that adjuvant aromatase inhibitor use with growth hormone therapy did not increase final adult height in male childhood cancer survivors. The retrospective cohort study included male childhood cancer survivors with growth hormone deficiency who were treated between 2007 and 2023. Patients (n=92) were treated with growth hormone...